Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Allen C. Ho, MD, and Robert L. Avery, MD
Paola Dorta S., MD, MHA, and Andrés Kychenthal B., MD
Lauren Lombardi; Lotem Nativ; Omar Helmy, MD; and Shlomit Schaal, MD, PhD
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Recent Supplements
Combining Advanced Visualization and Instrument Selection for Difficult Epiretinal Membranes
Supported by Zeiss
View Insert
Rising Stars: Yuxi Zheng, MD
Editorially independent supported by Abbvie and Regenxbio
One to Watch: Douglas R. Matsunaga, MD
Supporting Patients Throughout Their GA Journey
Editorially Independent Content, Supported With Advertising From Asetllas
One to Watch: Alexis Warren, MD
Rising Stars: Jonathan Lin, MD, PhD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE